• L01EJ01 Ruxolitinib 5 medications
• L01EJ02 Fedratinib 1 medications
• L01EJ04 3 medications

medicationsWithCode L01EJ

• Inrebic 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Fedratinib dihydrochloride monohydrate	117,3 mg

  ATC code: L01E, L01EJ, L01EJ02

  Manufacturer: Bristol-Myers Squibb Pharma Eeig

• Jakavi 10 mg tablets

  Form: tablets

  Active substance	Dosage
  RUXOLITINIB	10 mg

  ATC code: L01E, L01EJ, L01EJ01

  Manufacturer: Novartis Europharm Limited

• Jakavi 15 mg tablets

  Form: tablets

  Active substance	Dosage
  RUXOLITINIB	15 mg

  ATC code: L01E, L01EJ, L01EJ01

  Manufacturer: Novartis Europharm Limited

• Jakavi 20 mg tablets

  Form: tablets

  Active substance	Dosage
  RUXOLITINIB	20 mg

  ATC code: L01E, L01EJ, L01EJ01

  Manufacturer: Novartis Europharm Limited

• Jakavi 5 mg tablets

  Form: tablets

  Active substance	Dosage
  RUXOLITINIB	5 mg

  ATC code: L01E, L01EJ, L01EJ01

  Manufacturer: Novartis Europharm Limited

• Jakavi 5 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  RUXOLITINIB PHOSPHATE	6,60 mg/ml

  ATC code: L01E, L01EJ, L01EJ01

  Manufacturer: Novartis Europharm Limited

• Omjjara 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	121,94 mg

  ATC code: L01E, L01EJ, L01EJ04

  Manufacturer: Glaxosmithkline Trading Services Limited

• Omjjara 150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	182,91 mg

  ATC code: L01E, L01EJ, L01EJ04

  Manufacturer: Glaxosmithkline Trading Services Limited

• Omjjara 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	243,88 mg

  ATC code: L01E, L01EJ, L01EJ04

  Manufacturer: Glaxosmithkline Trading Services Limited